groups. Asthma symptom VAS was positively correlated with Rhinitis symptom VAS in the NOB group (r s = 0.353, P = 0.008), but not in the OB group (r s = -0.009, P = 0.971). BMI and Asthma symptom VAS were not significantly correlated in the NOB group (r s = 0.076, P = 0.581), but did show a trend for a positive correlation in the OB group (r s = 0.454, P = 0.050). There was no significant correlation between BMI and Rhinitis symptom VAS in the NOB and OB groups.
groups. Asthma symptom VAS was positively correlated with Rhinitis symptom VAS in the NOB group (r s = 0.353, P = 0.008), but not in the OB group (r s = -0.009, P = 0.971). BMI and Asthma symptom VAS were not significantly correlated in the NOB group (r s = 0.076, P = 0.581), but did show a trend for a positive correlation in the OB group (r s = 0.454, P = 0.050). There was no significant correlation between BMI and Rhinitis symptom VAS in the NOB and OB groups.
Conclusions: Obesity-related factors may affect asthma symptoms and control more than rhinitis-related factors in adult obese asthmatic patients. In addition, Real-time PCR was used to detect Drp-1 and Mfn-2 mRNA in ASMCs. Western blot was used to detect the expression of Drp-1, Mfn-2, PCNA and CyclinD1 the key proteins of ASMCs proliferation.
Results: Mab could inhibit PDGF-BB induced proliferation, migration and the increased of the Ca 2+ level of ASMCs in a dose-dependent manner. Mab could inhibit the increase of ROS and the S phase of ASMCs cycle, but promote the increase of MMP induced by PDGF-BB. Mab could inhibit the expression of mRNA and protein of Drp-1, promote the expression of mRNA and protein of Mfn-2, and inhibit PCNA and CyclinD1 proteins expression induced by PDGF-BB.
Conclusion:
These findings suggested that Mab could inhibit the proliferation and migration of PDGF-BB-induced rat ASMCs and the mechanism was related to the inhibition of intracellular Ca 2+ and mitochondrial fission, and the reduction of ROS level. Methods: Data was collected retrospectively from case notes of 148 asthmatic patients aged 17 to 82 whose outpatient total serum IgE was done from year 2011 to 2018 in Respiratory Clinic Hospital Taiping. Among these patients, only 137 had full blood count results and 86 had FEIA results. The diagnosis was confirmed via history, physical examination and spirometry with reversibility. Data collection also included demographics, smoking status, presence of allergic rhinitis, peripheral eosinophil percentage and age of onset of bronchial asthma.
Results: 89.9 % of the patients had elevated total serum IgE ( >100 kU/mL) and 65.7% had raised peripheral eosinophil percentage (≥3%). Mean total IgE and peripheral eosinophil percentage were 979 kU/mL and 5.0%. Males, early onset asthma and those with allergic rhinitis had higher average total IgE.
Among FEIA results, 80.3% were sensitized to at least one of the 3 house dust mites (HDM) species with 39.5% positive to all the three allergens. 33.7% were sensitized to grass pollen, followed by cockroach (29.1%), Aspergillus fumigatus (20.9%) and cat dander (10.4 %). 39.5% were sensitized to at least one of the seafood allergens but only 5 reported seafood allergy. Minority were sensitized to peanut and honey (4.6%).
Most asthmatic patients have elevated total IgE and peripheral eosinophil percentage. Sensitivity against HDM was the highest followed by seafood allergens, grass pollen, cockroach, Aspergillus fumigatus and cat dander. Hence we can advice patients with moderate to severe asthma to avoid these allergens especially HDM. Background and Aims: The increase of efficiency of mucociliary clearance with corticosteroids in asthmatics is connected with the decrease of mucus secretion and correction of the contents of goblet epithelium in airways. We aimed to study the correlation between the number of cells of goblet epithelium of bronchi and the level of asthma control in patients against the therapy with inhaled corticosteroids (ICS).
Methods: There were examined 33 subjects with mild asthma (mean FEV 1 was 90. AE .2%) with cold airway hyperresponsiveness that received a controller therapy with ICS/LABA in a low dose during 24 weeks. The patients were divided into two groups depending on the regularity of the using of ICS/LABA: 22 subjects received systematically controller therapy (1 st group); 11 subjects received irregularly ICS/LABA (2 nd group). The level of asthma control was assessed by Asthma Control Test (ACT, points). The content of the goblet cells was measured in the smears of the induced sputum (IS).
Results: The subjects of the 2 nd group had a lower level of asthma control in comparison with the patients of the 1 st group (15. AE .2 vs 21. AE .3 ACT points, respectively, P = 0.03) and lower FEV 1 (85. AE .2 and 95. AE .9%, respectively, P = 0.03). While studying IS, the contents of goblet cells in subjects of the 2 nd group was higher than in the 1 st group (0.3 AE .05 and 0.1 AE .4%, respectively, P = 0.043). According to the data of the correlation analysis a close correlation between the level of asthma control (ACT points) and the quantity of goblet cells in IS (r = −0.30; P = 0.019) was found out.
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